Please use this identifier to cite or link to this item:
Title: Adverse reactions and tolerability of high-dose sublingual allergen immunotherapy.
Issue Date: 2016
Citation: J Asthma Allergy.2016;(9):129-33
Abstract: Sublingual allergen immunotherapy is an effective treatment against allergic respiratory disease. Many studies have shown the safety of this type of therapy, although the factors that might affect the tolerability of high-dose sublingual immunotherapy have not been well established. The aim of this study was to determine the factors that affect the tolerability of sublingual allergen immunotherapy.
PMID: 27418842
Rights: openAccess
ISSN: 1178-6965
Appears in Collections:Hospitales > H. U. Infanta Sofía > Artículos

Files in This Item:
File Description SizeFormat 
PMC4935085.pdf263.65 kBAdobe PDFThumbnail

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.